These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37848905)

  • 1. Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.
    Zhang C; Yu Z; Gao S; Ma M; Gou L; Wang C; Wang L; Li J; Zhong L; Zhou Y; Wang W; Song H
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):124. PubMed ID: 37848905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
    Schwartz DM; Kitakule MM; Dizon BL; Gutierrez-Huerta C; Blackstone SA; Burma AM; Son A; Deuitch N; Rosenzweig S; Komarow H; Stone DL; Jones A; Nehrebecky M; Hoffmann P; Romeo T; de Jesus AA; Alehashemi S; Garg M; Torreggiani S; Montealegre Sanchez GA; Honer K; Souto Adeva G; Barron KS; Aksentijevich I; Ombrello AK; Goldbach-Mansky R; Kastner DL; Milner JD; Frischmeyer-Guerrerio P
    Ann Rheum Dis; 2021 Jun; 80(6):788-795. PubMed ID: 33619160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
    Fonollosa A; Pelegrín L; García-Morillo S; Buján-Rivas S; Distefano L; Robles-Maruenda A; Fernández-Martín J; González-García A; Garcia-Aparicio Á; Ortego-Centeno N; Llorenç V; Sainz de la Maza M; Pinedo C; Sopeña B; Cocho L; Carreño E; Blanco R; Antón J; Pérez-Quintana M; Marques-Soares JR; Artaraz J; Ruiz-Arruza I; Soto-Peleteiro A; Gómez-Caverzaschi V; Araújo O; Espinosa G; Adan A; Fabiani C; Cantarini L; Hernández-Rodríguez J;
    Clin Exp Rheumatol; 2023 Oct; 41(10):2105-2114. PubMed ID: 37812477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
    Silva GD; Mahler JV; da Silva Junior SRP; Mendonça LO; de Sá Barreto Lima PLG; Nóbrega PR; Kok F; Freua F
    BMC Neurol; 2024 Apr; 24(1):130. PubMed ID: 38632524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.
    Jain A; Misra DP; Sharma A; Wakhlu A; Agarwal V; Negi VS
    Rheumatol Int; 2018 Jan; 38(1):13-24. PubMed ID: 29032440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old Dogs, New Tricks: Monogenic Autoinflammatory Disease Unleashed.
    Stoffels M; Kastner DL
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():245-72. PubMed ID: 27362340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases.
    Sözeri B; Demir F; Sönmez HE; Karadağ ŞG; Demirkol YK; Doğan ÖA; Doğanay HL; Ayaz NA
    Clin Rheumatol; 2021 Jun; 40(6):2327-2337. PubMed ID: 33165748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
    Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
    Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic.
    Alenazi A; Al Sonbul A; Al Jumaah S; Al Mehaidib A; Al-Mayouf SM
    Ann Saudi Med; 2012; 32(1):43-8. PubMed ID: 22156639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
    Ozen S; Demir S
    Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
    Kuemmerle-Deschner JB; Kallinich T; Henes J; Kortus-Götze B; Oommen PT; Rech J; Krickau T; Weller-Heinemann F; Horneff G; Janda A; Foeldvari I; Schuetz C; Dressler F; Borte M; Hufnagel M; Meier F; Fiene M; Andreica I; Weber-Arden J; Blank N
    RMD Open; 2024 Feb; 10(1):. PubMed ID: 38360038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic autoinflammatory diseases: concept and clinical manifestations.
    Almeida de Jesus A; Goldbach-Mansky R
    Clin Immunol; 2013 Jun; 147(3):155-74. PubMed ID: 23711932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
    Kanazawa N; Ishii T; Takita Y; Nishikawa A; Nishikomori R
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):38. PubMed ID: 37087470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic fever syndromes.
    Lachmann HJ
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):596-609. PubMed ID: 29773275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic algorithms for monogenic autoinflammatory diseases presenting with recurrent fevers among adults.
    Delplanque M; Fayand A; Boursier G; Grateau G; Savey L; Georgin-Lavialle S
    Rheumatology (Oxford); 2023 Aug; 62(8):2665-2672. PubMed ID: 36575989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
    Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience.
    Suri D; Rawat A; Jindal AK; Vignesh P; Gupta A; Pilania RK; Joshi V; Arora K; Kumrah R; Anjani G; Aggarwal A; Phadke S; Aboobacker FN; George B; Edison ES; Desai M; Taur P; Gowri V; Pandrowala AA; Bhattad S; Kanakia S; Gottorno M; Ceccherini I; Almeida de Jesus A; Goldbach-Mansky R; Hershfield MS; Singh S
    Front Immunol; 2021; 12():630691. PubMed ID: 33815380
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
    Balci S; Ekinci RMK; Dogruel D; Altintas DU; Yilmaz M
    Indian Pediatr; 2020 Jul; 57(7):637-640. PubMed ID: 32727940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Eurofever Project: towards better care for autoinflammatory diseases.
    Ozen S; Frenkel J; Ruperto N; Gattorno M;
    Eur J Pediatr; 2011 Apr; 170(4):445-52. PubMed ID: 21360011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.